Q4 2023 Holdings
Filed 2024-02-14 | 216 holdings | $149.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rithm Capital Corp(RITM) | COM NEW | 64828T201 | $4.3M | 400,966 | 2.9% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $4.3M | 105,000 | 2.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.0M | 675,000 | 2.7% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $4.0M | 117,500 | 2.7% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $3.9M | 122,000 | 2.6% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $3.8M | 200,000 | 2.5% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $3.8M | 127,500 | 2.5% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $3.3M | 1,000,000 | 2.2% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $3.1M | 120,000 | 2.1% |
| Two Harbors Inventment Corpo | NOTE 6.250% 1/1 | 90187BAB7 | $3.0M | 3,205,000 | 2.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $2.9M | 7,750 | 2.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $2.9M | 267,500 | 1.9% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.9M | 421,025 | 1.9% |
| Ellington Financial Inc(EFC) | COM | 28852N109 | $2.8M | 221,602 | 1.9% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $2.8M | 245,000 | 1.9% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $2.3M | 155,000 | 1.6% |
| Pfizer Inc(PFE) | COM | 717081103 | $2.3M | 80,000 | 1.5% |
| Dynex Cap Inc(DX) | COM | 26817Q886 | $2.3M | 181,492 | 1.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $2.2M | 151,000 | 1.5% |
| RWT Hldgs Inc | NOTE 5.750%10/0 | 749772AD1 | $2.1M | 2,284,000 | 1.4% |
| Invesco Exch Traded FD TR II(QQQM) | NASDAQ 100 ETF | 46138G649 | $2.1M | 12,478 | 1.4% |
| Invesco QQQ TR(QQQ) | UNIT SER 1 | 46090E103 | $2.1M | 5,122 | 1.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $2.0M | 140,000 | 1.3% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $1.9M | 220,000 | 1.3% |
| Pennymac Corp | NOTE 5.500%11/0 | 70932AAD5 | $1.9M | 1,965,000 | 1.3% |
| Docgo Inc(DCGO) | COM | 256086109 | $1.7M | 310,000 | 1.2% |
| New York MTG TR Inc(ADAM) | COM | 649604840 | $1.7M | 200,963 | 1.2% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $1.7M | 20,500 | 1.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.7M | 137,000 | 1.1% |
| MFA Finl Inc(MFA) | COM | 55272X607 | $1.6M | 142,725 | 1.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $1.6M | 38,000 | 1.1% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $1.6M | 668,151 | 1.0% |
| Mgic Invt Corp WIS(MTG) | COM | 552848103 | $1.5M | 79,379 | 1.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $1.5M | 50,000 | 1.0% |
| Equity Lifestyle Pptys Inc(ELS) | COM | 29472R108 | $1.5M | 20,611 | 1.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $1.4M | 20,000 | 1.0% |
| MR Cooper Group Inc(07WA) | COM | 62482R107 | $1.4M | 21,591 | 0.9% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $1.4M | 100,000 | 0.9% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $1.4M | 7,500 | 0.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.3M | 14,000 | 0.9% |
| AG MTG Invt TR Inc(MITT) | COM NEW | 001228501 | $1.3M | 208,879 | 0.9% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $1.3M | 35,000 | 0.9% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $1.3M | 10,500 | 0.9% |
| Symbotic Inc(SYM) | CLASS A COM | 87151X101 | $1.3M | 25,000 | 0.9% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $1.3M | 3,750 | 0.8% |
| Enact Hldgs Inc(ACT) | COM | 29249E109 | $1.2M | 42,367 | 0.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $1.2M | 30,000 | 0.8% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.2M | 150,000 | 0.8% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $1.1M | 40,000 | 0.8% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $1.1M | 56,000 | 0.7% |